Pricing Log in Create free account

Alaunos Therapeutics, Inc. (TCRT) vs VistaGen Therapeutics, Inc. (VTGN)

Alaunos Therapeutics, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Alaunos Therapeutics, Inc. and VistaGen Therapeutics, Inc. are of similar size ($7.6M and $7.3M). VistaGen Therapeutics, Inc. grew revenue faster over the last twelve months: 287.2% against −17.7%. Alaunos Therapeutics, Inc. has the higher net margin (0.00% vs −2,703.7%) and the lower return on invested capital (−480.4% vs 0.00%). Across the 16 metrics below, Alaunos Therapeutics, Inc. leads on 8 and VistaGen Therapeutics, Inc. on 8.

Valuation

Metric TCRT VTGN Biotechnology median
P/E n/m n/m 10.60
P/S 312.69 2.92 9.40
P/B 6.71 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.23 0.66
EV/Sales 1,408.11 (6.44) 9.02
Earnings yield (107.37%) (976.47%) (32.88%)
Free cash flow yield (30.18%) (854.68%) (23.13%)

Profitability

Metric TCRT VTGN Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (2,785.69%) 0.00%
Net margin 0.00% (2,703.72%) 0.00%
Free cash flow margin 0.00% (2,490.88%) 0.00%
Return on equity (185.95%) (166.46%) (51.96%)
Return on assets (128.30%) (129.22%) (46.06%)
Return on invested capital (480.35%) 0.00% 0.00%

Growth

Metric TCRT VTGN Biotechnology median
Revenue growth (TTM) (17.65%) 287.15% 6.76%
EPS growth (last fiscal year) 24.66% (9.58%) 29.88%
Revenue growth, 5-year CAGR (49.08%) 3.10% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TCRT VTGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.77 3.07 4.97
Net debt to EBITDA 0.33 0.63 1.01

Dividend

Metric TCRT VTGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TCRT VTGN Biotechnology median
Market cap 7.60m 7.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack